Multiple SclerosisEMS_RehabNCT07805733
Early Symptoms in Multiple Sclerosis: an Investigation Using fMRI and Gait Analysis to Develop Personalized Balance Training for People With Low Disability
A study testing Vestibular Physical Therapy in people with Multiple Sclerosis, run by LIFE - Research and Care Institute - Santa Lucia IRCCS.
Trial summary
Background Many people with Multiple Sclerosis (MS) experience a hidden yet clinically significant symptom: impaired balance or a persistent feeling of instability, even during the early stages of the disease (Martin et al., 2006). Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Multiple Sclerosis
- What is being tested?
- Vestibular Physical Therapy
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- No sites listed yet
- Study dates
- 1 Oct 2026to 1 Oct 2029
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- people with Relapsing-Remitting Multiple Sclerosis;
- All participants must be ambulatorial (EDSS ≤2.5);
Who cannot join
- relapse or medication changes in the prior 6 months;
- people with peripheral vestibular disorders;
- people with contraindications to MRI.
- We will also recruit 30 healthy volunteers, matched for age and sex, who will complete the assessment protocol once, to serve as a comparison group for individuals with MS.
About this study
Background
Many people with Multiple Sclerosis (MS) experience a hidden yet clinically significant symptom: impaired balance or a persistent feeling of instability, even during the early stages of the disease (Martin et al., 2006). Although these individuals may appear to walk normally, they often report feeling unsteady, avoiding crowded environments, or fearing falls. In some cases, however, balance deficits become overt and disabling, depending on the location and extent of lesions within the central nervous system. This heterogeneity complicates both the assessment and treatment of balance disorders in MS and highlights the need for personalized evaluation and rehabilitation strategies (Carpinella et al., 2022).
Read more
Because early balance impairments are often subtle, they tend to be underestimated in clinical practice and may remain untreated for months or even years. This delay can negatively affect confidence, mobility, safety, and overall quality of life. The present project seeks to address this gap by promoting early identification and intervention before substantial disability develops.
Project Objectives
The objectives of this project are:
To identify the mechanisms underlying early balance impairment in people with MS.
To develop and evaluate an early intervention based on Vestibular Physical Therapy (VPT) that specifically targets sensory reweighting and visuo-vestibular integration. The rehabilitation program is designed to improve gaze stability and saccadic velocity, both of which are essential for maintaining postural control and dynamic balance. In addition, functional magnetic resonance imaging (fMRI) will be used to investigate the neurophysiological mechanisms underlying the intervention, providing insight into how the brain adapts to vestibular stimulation.
If successful, this approach could enable clinicians to detect and treat balance impairments at an earlier stage, using objective and measurable changes in gait and brain function as biomarkers of rehabilitation efficacy.
Methodology
The study will recruit two groups of participants:
Individuals diagnosed with Multiple Sclerosis (Thompson et al., 2018; Wallace et al., 2025) with mild disability (Expanded Disability Status Scale, EDSS ≤ 2.5) who report balance complaints.
Healthy volunteers matched for age and sex.
At baseline (T0), all participants will undergo a comprehensive assessment including:
Structural and functional MRI with vestibular stimulation to investigate the integrity and functional organization of the vestibular network.
Instrumented gait analysis using wearable inertial sensors (Castiglia et al., 2025).
Validated clinical scales and questionnaires assessing objective balance performance, perceived stability, fear of falling, fall risk, and health-related quality of life.
Participants with MS will then be randomly assigned to one of two groups:
Intervention group: Participants will receive a structured Vestibular Physical Therapy (VPT) program consisting of 12 sessions (three sessions per week). Unlike conventional vestibular rehabilitation, this protocol specifically focuses on sensory reweighting and visuo-vestibular integration to enhance gaze stability, saccadic velocity, and postural control.
Control group: Participants will continue receiving standard clinical care for MS without additional vestibular rehabilitation during the initial study phase.
Following completion of the 12-session intervention, all participants will repeat the full assessment battery (T1) to evaluate changes in gait performance, balance, patient-reported outcomes, and brain function.
After a 4-week washout period, a crossover design will be implemented, with participants switching to the alternate treatment arm for an additional 12-session period, followed by a final assessment (T2). Participants initially assigned to the control group will not require a washout period before crossing over to the intervention, as they will not have received VPT during the first phase of the study.
Read the detailed description
Balance dysfunction is one of the most frequent and disabling symptoms of relapsing-remitting Multiple Sclerosis (RRMS), affecting up to 80% of people with MS (Alayidi et al., 2025). Importantly, subtle impairments in balance and gait emerge even in the earliest stages of the disease, when clinical disability remains minimal (Expanded Disability Status Scale [EDSS] ≤ 2.5) (Caronni et al., 2020). Many individuals report feelings of instability, dizziness, or unsteadiness despite having a normal neurological examination, while conventional clinical tests often fail to detect these early deficits (Carpinella et al., 2022). Consequently, balance impairment in early RRMS is frequently considered a "hidden disability," negatively affecting confidence, mobility, and quality of life long before overt disability develops.
Current evidence suggests that early balance dysfunction in MS is primarily driven by impaired sensory integration rather than muscle weakness. In particular, disruption of proprioceptive pathways reduces the accuracy of sensory feedback required for postural control (Fling et al., 2014). To compensate for this deficit, the central nervous system appears to increase reliance on cortical attentional mechanisms. Functional MRI studies support this hypothesis by demonstrating increased activation of the primary sensorimotor cortex and supplementary motor areas during simple motor tasks in people with early MS, reflecting compensatory neural recruitment (Rocca et al., 2022).
From a clinical perspective, individuals with early RRMS frequently report reduced balance confidence and fear of falling despite maintaining relatively normal motor performance. Patient-reported outcome measures, such as the Activities-specific Balance Confidence (ABC) Scale and the Dizziness Handicap Inventory (DHI), are effective in capturing perceived instability, particularly during static activities. However, these questionnaires provide limited information regarding dynamic balance performance. Conversely, objective instrumented assessments have demonstrated that subtle abnormalities in gait are already present during the earliest disease stages, even when standard neurological examinations remain normal (Muller et al., 2021).
Recent advances in wearable sensor technology have substantially improved the assessment of gait and balance in MS. Inertial Measurement Units (IMUs) allow precise quantification of spatiotemporal gait parameters during daily activities and standardized walking tests. Previous studies have shown that individuals with early RRMS exhibit slower walking speed, shorter stride length, and prolonged double-support time compared with healthy controls, despite having EDSS scores between 1 and 2 (Soyuer et al., 2006; Benedetti et al., 1999; Karst et al., 2005). These alterations correlate with fatigue and self-perceived disability, suggesting that wearable sensors detect clinically meaningful impairments before they become apparent during routine neurological examination.
The diagnostic sensitivity of IMU-based assessments is particularly evident during postural control tasks. Carpinella et al. (2022) demonstrated that advanced analysis of quiet standing using wearable sensors was three to four times more sensitive than conventional Romberg testing. Specifically, early RRMS participants exhibited reduced sway complexity and increased trunk oscillations, allowing balance impairment to be identified in 58% of participants compared with only 17% detected using traditional clinical assessment. These findings strongly support the integration of wearable technologies into the early evaluation of balance dysfunction in MS.
Although neuroimaging studies have documented widespread functional reorganization in MS, relatively little is known about the neural mechanisms specifically underlying vestibular dysfunction and balance impairment during the early stages of the disease. Task-based fMRI consistently demonstrates increased activation of sensorimotor cortical regions, suggesting compensatory recruitment of motor networks, while resting-state studies reveal altered connectivity within sensorimotor and vestibular circuits. Furthermore, diffusion tensor imaging studies have shown that the structural integrity of proprioceptive pathways predicts balance performance in people with MS (Fling et al., 2014). Nevertheless, to our knowledge, no previous study has combined functional MRI with balance-related vestibular stimulation to directly investigate the neural correlates of early balance impairment in RRMS. This represents a significant knowledge gap.
Immersive virtual reality (VR) offers an innovative approach for investigating balance control under controlled sensory conflict conditions. Beyond its diagnostic potential, VR may also serve as a rehabilitation tool by repeatedly exposing patients to visual and vestibular challenges that promote sensory reweighting. Recent technological developments have led to the creation of MRI-compatible VR systems capable of presenting gaze-controlled visual environments during brain imaging. Such platforms provide the opportunity to investigate how the brain processes balance-related visual and vestibular stimuli in vivo and may eventually facilitate the development of individualized neurorehabilitation protocols.
Vestibular Physical Therapy (VPT) represents one of the most promising rehabilitation strategies for addressing balance dysfunction in MS. VPT consists of structured exercises involving head and eye movements, gaze stabilization, postural control, and balance tasks designed to promote central vestibular compensation (Tramontano et al., 2025). Although vestibular dysfunction in MS is often central rather than peripheral in origin, growing evidence supports the effectiveness of VPT in improving both dizziness and balance (Tramontano et al., 2021).
A recent meta-analysis demonstrated that vestibular rehabilitation significantly improves balance performance and reduces dizziness compared with no intervention in people with MS, with large clinical effect sizes (García-Muñoz et al., 2020). Although vestibular rehabilitation was not statistically superior to other forms of exercise therapy, it consistently produced greater improvements across studies. Similarly, Smania et al. (2015) showed that sensory integration-based balance training resulted in significantly greater improvements in balance performance, reduced falls, and increased balance confidence compared with conventional rehabilitation.
The beneficial effects of VPT are believed to result from adaptive neuroplastic mechanisms. Vestibular rehabilitation facilitates sensory reweighting by enhancing the integration of visual, vestibular, and proprioceptive information while promoting adaptation of vestibulo-ocular and vestibulo-spinal reflexes. Experimental animal studies further suggest that structured vestibular rehabilitation induces cellular plasticity within vestibular nuclei, accelerating functional recovery through increased microgliogenesis and regulation of neurogenesis (Marouane et al., 2021). In humans, neurorehabilitation studies have similarly reported increased functional connectivity within cerebellar and sensorimotor networks following rehabilitation, supporting the hypothesis that VPT promotes adaptive reorganization of central balance networks.
Despite these advances, important unmet clinical needs remain. First, currently available clinical assessments lack sufficient sensitivity to detect early balance impairment in RRMS. Standard neurological examination and conventional balance tests frequently fail to identify subtle deficits that are readily detected using wearable technologies. Second, the neural mechanisms underlying early balance dysfunction remain poorly understood, particularly regarding the interaction between vestibular, cerebellar, and cortical networks. Finally, vestibular rehabilitation is generally introduced only after moderate disability has developed (EDSS 3-6), despite evidence that many patients experience instability much earlier. This delay represents a missed opportunity for preventive intervention aimed at preserving mobility and reducing long-term disability.
These limitations provide a strong rationale for the proposed study. By combining objective gait analysis using wearable inertial sensors, advanced functional neuroimaging with vestibular stimulation, and an early Vestibular Physical Therapy program specifically targeting visuo-vestibular integration and sensory reweighting, this project seeks to characterize the mechanisms underlying early balance impairment in RRMS and determine whether timely intervention can modify both functional performance and the neural substrates of balance control. Demonstrating the efficacy of early VPT could support a paradigm shift toward proactive rehabilitation in Multiple Sclerosis, enabling clinicians to identify and treat balance dysfunction before irreversible disability develops.
Hypothesis
We hypothesize that individuals with early relapsing-remitting Multiple Sclerosis (RRMS; EDSS ≤ 2.5) exhibit measurable neurophysiological alterations within vestibular and sensorimotor networks despite minimal clinical disability, and that these alterations contribute to the subtle balance impairments commonly reported during the early stages of the disease. We further hypothesize that a targeted Vestibular Physical Therapy (VPT) program, specifically designed to promote sensory reweighting and visuo-vestibular integration, will improve both subjective symptoms and objective balance performance while inducing adaptive neuroplastic changes detectable by functional MRI (fMRI).
Specifically, we propose that the "hidden" imbalance observed in early RRMS reflects compensatory or maladaptive plasticity within vestibular, cerebellar, and sensorimotor circuits. These alterations are expected to manifest as abnormal patterns of functional activation and connectivity on fMRI. By engaging vestibular pathways through a structured rehabilitation program, we anticipate promoting adaptive reorganization of these networks, resulting in improved balance control, enhanced gaze stability, and normalization of functional brain connectivity.
This hypothesis is supported by previous evidence demonstrating increased activation of sensorimotor and vestibular cortical regions during motor tasks in early MS, as well as studies showing that motor rehabilitation modifies functional connectivity in people with MS. Furthermore, vestibular rehabilitation has been shown to induce cerebellar and brainstem plasticity in other neurological populations. However, no previous study has directly investigated these mechanisms in early RRMS using an integrated multimodal approach combining functional neuroimaging, quantitative gait analysis, and vestibular rehabilitation.
Specific Aims Aim 1. Identify the Neuroimaging Correlates of Early Balance Dysfunction
Participants will undergo structural and functional MRI using advanced imaging protocols to characterize the functional organization of vestibular, sensorimotor, cerebellar, and balance-related brain networks. Functional imaging will include vestibular stimulation paradigms, such as controlled acoustic stimulation and, where feasible, visual motion stimuli presented through MRI-compatible immersive virtual reality.
We hypothesize that individuals with RRMS will demonstrate altered functional connectivity among key regions involved in balance control, including the cerebellum, parietal cortex, vestibular brainstem nuclei, and sensorimotor cortex, compared with healthy controls. Furthermore, we expect these neuroimaging abnormalities to correlate with the severity of balance impairment measured through objective gait analysis, providing neurophysiological biomarkers of early balance dysfunction.
Aim 2. Characterize Early Balance Impairment Using Advanced Clinical and Instrumented Measures
Subjective and objective balance performance will be comprehensively evaluated using validated clinical questionnaires, standardized balance assessments, and wearable inertial measurement units (IMUs).
Patient-reported outcomes will include measures of dizziness, balance confidence, and quality of life, while IMUs will quantify gait characteristics-including walking speed, stride length, gait symmetry, smoothness, and postural stability-during standardized walking tasks and quiet standing.
We expect people with early RRMS (EDSS ≤ 2.5) to exhibit measurable impairments in gait and postural control despite minimal disability on conventional neurological examination, confirming the presence of clinically hidden balance dysfunction.
Aim 3. Evaluate the Effects of Targeted Vestibular Physical Therapy
We will conduct a randomized crossover clinical trial in which each participant serves as their own control, thereby maximizing statistical power while minimizing inter-individual variability.
Participants will complete both:
a 4-week Vestibular Physical Therapy (VPT) program consisting of 12 sessions specifically designed to enhance sensory reweighting, visuo-vestibular integration, gaze stability, and saccadic function; and a 4-week control period consisting of standard clinical management without additional vestibular rehabilitation.
Participants initially randomized to the intervention arm will undergo a 4-week washout period before crossing over to the control condition, whereas no washout will be required for participants initially assigned to the control arm.
Clinical assessments, quantitative gait analysis, and functional MRI will be performed before and after each intervention period.
We hypothesize that VPT will produce significantly greater improvements in balance performance, gait parameters, dizziness, and fatigue compared with the control condition. We further expect these functional improvements to be accompanied by adaptive changes in brain connectivity, including normalization of excessive cerebellar-sensorimotor coupling and enhanced integration within vestibular networks.
Importantly, vestibular stimulation delivered during fMRI through controlled acoustic stimuli will provide a direct measure of functional changes within vestibular pathways following rehabilitation, offering mechanistic insight into the neural effects of VPT on postural control and gaze stabilization.
Aim 4. Develop Integrated Biomarkers of Early Balance Dysfunction and Rehabilitation Response
Finally, we will integrate quantitative gait metrics obtained from wearable sensors with functional neuroimaging data to identify multimodal biomarkers of early balance impairment.
Specifically, we will investigate whether individuals exhibiting greater abnormalities in gait and postural control also demonstrate more pronounced alterations in vestibular network connectivity. We will additionally evaluate whether changes in these imaging biomarkers predict clinical improvement following rehabilitation.
The identification of objective biomarkers linking behavior and brain function could facilitate earlier diagnosis, improve patient stratification, and provide sensitive outcome measures for future rehabilitation trials.
- Conditions
- Multiple Sclerosis
- Being tested
- Vestibular Physical Therapy
- Keywords
- Multiple Sclerosis, Vestibular Physical Therapy, Gait Analysis, fMRI
- Medical subject headings
- Multiple Sclerosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Vestibular Physical TherapyOther
Vestibular Physical Therapy sessions realized focusing on visuo-vestibular interaction (12 session, 3 x 4 weeks)
| Study group | Role | What they receive |
|---|---|---|
| VPT | Experimental | People in this arm will be treated with a vestibular physical therapy programme. Receives: Other: Vestibular Physical Therapy |
| No VPT | No intervention | People in this arm will receive a no-add-on-intervention period |
| Healty control | No intervention | A healthy control group is required to enable comparisons between individuals with MS and healthy participants. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Mini-BESTest
is a 14-item scale (0-28) measures anticipatory postural adjustments, reactive control, sensory orientation and dynamic gait. It is validated and reliable in people with MS. Test-retest reliability is "good to excellent" in mild/moderate MS. Higher scores indicate better balance stability.
Measured: Baseline (T0), after first intervention period (T1; 4 weeks), and after crossover (T2; 8 weeks).
Secondary outcomes (7)
Neuroimaging (MRI)
Structural and functional MRI on a 3 T scanner will assess brain integrity, connectivity and activity, in particular related to visual optic flow or vestibular stimuli. A 3 T scanner yields high signal-to-noise and improved BOLD sensitivity versus 1.5 T, increasing our ability to detect treatment-related neural changes. Pre/post fMRI (same paradigm each time) will be done at baseline and after each intervention. Imaging data analysis will focus on balance and vestibular networks, comparing activation and connectivity changes with intervention.
Measured: Baseline (T0), after first intervention period (T1; 4 weeks), and after crossover (T2; 8 weeks).
Berg Balance Scale (BBS)
Static and dynamic balance assessment (Score range: 0-56, with higher scores indicating better balance performance and lower fall risk).
Measured: Baseline (T0), after first intervention period (T1; 4 weeks), and after crossover (T2; 8 weeks).
Dizziness Handicap Inventory (DHI)
The Dizziness Handicap Inventory (DHI) is a validated, self-administered questionnaire consisting of 25 items that assesses the self-perceived impact of dizziness and balance disorders on daily life. The questionnaire evaluates three domains: Functional (9 items), Emotional (9 items), and Physical (7 items). Each item is scored as 0 (No), 2 (Sometimes), or 4 (Yes), yielding a total score ranging from 0 to 100, with higher scores indicating greater perceived disability due to dizziness.
Measured: Baseline (T0), after the first intervention period (T1; 4 weeks), and after the crossover intervention (T2; 8 weeks).
Activities-specific Balance Confidence (ABC) Scale
The Activities-specific Balance Confidence (ABC) Scale is a validated self-reported questionnaire that assesses an individual's confidence in maintaining balance while performing 16 common daily activities without becoming unsteady or losing balance. Participants rate their confidence for each activity on a scale from 0 (no confidence) to 100 (complete confidence). The overall score is calculated as the average of all item scores, resulting in a total score ranging from 0 to 100, with higher scores indicating greater balance confidence.
Measured: Baseline (T0), after the first intervention period (T1; 4 weeks), and after the crossover intervention (T2; 8 weeks).
Fatigue Severity Scale
The Fatigue Severity Scale (FSS) is a validated self-administered questionnaire used to assess the severity of fatigue and its impact on daily functioning. The scale consists of 9 items, each rated on a 7-point Likert scale, ranging from 1 (strongly disagree) to 7 (strongly agree). The final score is calculated as the mean of the 9 item scores, resulting in a total score ranging from 1 to 7. Higher scores indicate greater fatigue severity. An average score of ≥4 is generally considered indicative of clinically significant fatigue in people with Multiple Sclerosis.
Measured: Baseline (T0), after the first intervention period (T1; 4 weeks), and after the crossover intervention (T2; 8 weeks).
Inertial Measurement Unit (IMU)-derived Gait Parameters
Quantitative measures spatiotemporal gait parameters
Measured: Baseline (T0), after the first intervention period (T1; 4 weeks), and after the crossover intervention (T2; 8 weeks).
IMU-derived Gait Parameters
Quantitative measures of stability and smoothness of gait
Measured: Baseline (T0), after the first intervention period (T1; 4 weeks), and after the crossover intervention (T2; 8 weeks).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Sep 2026
- Study start1 Oct 2026 (estimated)
- Primary completion1 Oct 2028 (estimated)
- Study completion1 Oct 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Multiple SclerosisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- LIFE - Research and Care Institute - Santa Lucia IRCCS
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Maria Grazia Grasso, MD, PhD, Principal investigator, LIFE - Research and Care Institute - Santa Lucia IRCCSDiego Piatti, PT, MSc, Study director, LIFE - Research and Care Institute - Santa Lucia IRCCSIole Indovina, PhD, Study chair, LIFE - Research and Care Institute - Santa Lucia IRCCSGianfranco Bosco, MD, PhD, Study chair, LIFE - Research and Care Institute - Santa Lucia IRCCSGiorgia Presicce, MD, PhD, Study chair, LIFE - Research and Care Institute - Santa Lucia IRCCSGianluca Paolocci, PhD, Study chair, LIFE - Research and Care Institute - Santa Lucia IRCCSMarco Tramontano, PhD, Study chair, University of Bologna
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07805733
- Sponsor's protocol ID
- 538/SL/26
- Acronym
- EMS_Rehab
- Status last verified
- Jul 2026
- First submitted
- 1 Sep 2026
- Last updated
- 4 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Tramontano M, Paolocci G, Piatti D, Attanasio G, Casagrande Conti L, Bergamini E, Manzari L, Lacquaniti F, Staab JP, Bosco G, Indovina I. Dynamic postural stability, symmetry, and smoothness of gait in patients with persistent postural-perceptual dizziness. J Vestib Res. 2025 Mar;35(2):82-90. doi: 10.1177/09574271241295615. Epub 2024 Nov 6.
PubMed 39973598Piatti D, Paolocci G, Verdecchia DH, Grasso MG, Bosco G, Indovina I, Tramontano M. Effectiveness of vestibular physical therapy on balance and dizziness in people with multiple sclerosis: A systematic review and meta-analysis. J Vestib Res. 2026 May 5:9574271261444952. doi: 10.1177/09574271261444952. Online ahead of print.
PubMed 42084487Caronni A, Gervasoni E, Ferrarin M, Anastasi D, Brichetto G, Confalonieri P, Di Giovanni R, Prosperini L, Tacchino A, Solaro C, Rovaris M, Cattaneo D, Carpinella I. Local Dynamic Stability of Gait in People With Early Multiple Sclerosis and No-to-Mild Neurological Impairment. IEEE Trans Neural Syst Rehabil Eng. 2020 Jun;28(6):1389-1396. doi: 10.1109/TNSRE.2020.2991636. Epub 2020 Apr 30.
PubMed 32356754
Study at a glance
From the registry record, last updated by the sponsor on 4 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Early Symptoms in Multiple Sclerosis: an Investigation Using fMRI and Gait Analysis to Develop Personalized Balance Training for People With Low Disability
- ClinicalTrials.gov ID
- NCT07805733
- Acronym / sponsor ID
- EMS_Rehab / 538/SL/26
- Conditions
- Multiple Sclerosis
- Keywords
- Multiple Sclerosis, Vestibular Physical Therapy, Gait Analysis, fMRI
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- LIFE - Research and Care Institute - Santa Lucia IRCCSUniversity, hospital or other
- Study start
- 1 Oct 2026 (estimated)
- Primary completion
- 1 Oct 2028 (estimated)
- Study completion
- 1 Oct 2029 (estimated)
- First posted
- 4 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background
Many people with Multiple Sclerosis (MS) experience a hidden yet clinically significant symptom: impaired balance or a persistent feeling of instability, even during the early stages of the disease (Martin et al., 2006). Although these individuals may appear to walk normally, they often report feeling unsteady, avoiding crowded environments, or fearing falls. In some cases, however, balance deficits become overt and disabling, depending on the location and extent of lesions within the central nervous system. This heterogeneity complicates both the assessment and treatment of balance disorders in MS and highlights the need for personalized evaluation and rehabilitation strategies (Carpinella et al., 2022).
Because early balance impairments are often subtle, they tend to be underestimated in clinical practice and may remain untreated for months or even years. This delay can negatively affect confidence, mobility, safety, and overall quality of life. The present project seeks to address this gap by promoting early identification and intervention before substantial disability develops.
Project Objectives
The objectives of this project are:
To identify the mechanisms underlying early balance impairment in people with MS.
To develop and evaluate an early intervention based on Vestibular Physical Therapy (VPT) that specifically targets sensory reweighting and visuo-vestibular integration. The rehabilitation program is designed to improve gaze stability and saccadic velocity, both of which are essential for maintaining postural control and dynamic balance. In addition, functional magnetic resonance imaging (fMRI) will be used to investigate the neurophysiological mechanisms underlying the intervention, providing insight into how the brain adapts to vestibular stimulation.
If successful, this approach could enable clinicians to detect and treat balance impairments at an earlier stage, using objective and measurable changes in gait and brain function as biomarkers of rehabilitation efficacy.
Methodology
The study will recruit two groups of participants:
Individuals diagnosed with Multiple Sclerosis (Thompson et al., 2018; Wallace et al., 2025) with mild disability (Expanded Disability Status Scale, EDSS ≤ 2.5) who report balance complaints.
Healthy volunteers matched for age and sex.
At baseline (T0), all participants will undergo a comprehensive assessment including:
Structural and functional MRI with vestibular stimulation to investigate the integrity and functional organization of the vestibular network.
Instrumented gait analysis using wearable inertial sensors (Castiglia et al., 2025).
Validated clinical scales and questionnaires assessing objective balance performance, perceived stability, fear of falling, fall risk, and health-related quality of life.
Participants with MS will then be randomly assigned to one of two groups:
Intervention group: Participants will receive a structured Vestibular Physical Therapy (VPT) program consisting of 12 sessions (three sessions per week). Unlike conventional vestibular rehabilitation, this protocol specifically focuses on sensory reweighting and visuo-vestibular integration to enhance gaze stability, saccadic velocity, and postural control.
Control group: Participants will continue receiving standard clinical care for MS without additional vestibular rehabilitation during the initial study phase.
Following completion of the 12-session intervention, all participants will repeat the full assessment battery (T1) to evaluate changes in gait performance, balance, patient-reported outcomes, and brain function.
After a 4-week washout period, a crossover design will be implemented, with participants switching to the alternate treatment arm for an additional 12-session period, followed by a final assessment (T2). Participants initially assigned to the control group will not require a washout period before crossing over to the intervention, as they will not have received VPT during the first phase of the study.
Detailed description
Balance dysfunction is one of the most frequent and disabling symptoms of relapsing-remitting Multiple Sclerosis (RRMS), affecting up to 80% of people with MS (Alayidi et al., 2025). Importantly, subtle impairments in balance and gait emerge even in the earliest stages of the disease, when clinical disability remains minimal (Expanded Disability Status Scale [EDSS] ≤ 2.5) (Caronni et al., 2020). Many individuals report feelings of instability, dizziness, or unsteadiness despite having a normal neurological examination, while conventional clinical tests often fail to detect these early deficits (Carpinella et al., 2022). Consequently, balance impairment in early RRMS is frequently considered a "hidden disability," negatively affecting confidence, mobility, and quality of life long before overt disability develops.
Current evidence suggests that early balance dysfunction in MS is primarily driven by impaired sensory integration rather than muscle weakness. In particular, disruption of proprioceptive pathways reduces the accuracy of sensory feedback required for postural control (Fling et al., 2014). To compensate for this deficit, the central nervous system appears to increase reliance on cortical attentional mechanisms. Functional MRI studies support this hypothesis by demonstrating increased activation of the primary sensorimotor cortex and supplementary motor areas during simple motor tasks in people with early MS, reflecting compensatory neural recruitment (Rocca et al., 2022).
From a clinical perspective, individuals with early RRMS frequently report reduced balance confidence and fear of falling despite maintaining relatively normal motor performance. Patient-reported outcome measures, such as the Activities-specific Balance Confidence (ABC) Scale and the Dizziness Handicap Inventory (DHI), are effective in capturing perceived instability, particularly during static activities. However, these questionnaires provide limited information regarding dynamic balance performance. Conversely, objective instrumented assessments have demonstrated that subtle abnormalities in gait are already present during the earliest disease stages, even when standard neurological examinations remain normal (Muller et al., 2021).
Recent advances in wearable sensor technology have substantially improved the assessment of gait and balance in MS. Inertial Measurement Units (IMUs) allow precise quantification of spatiotemporal gait parameters during daily activities and standardized walking tests. Previous studies have shown that individuals with early RRMS exhibit slower walking speed, shorter stride length, and prolonged double-support time compared with healthy controls, despite having EDSS scores between 1 and 2 (Soyuer et al., 2006; Benedetti et al., 1999; Karst et al., 2005). These alterations correlate with fatigue and self-perceived disability, suggesting that wearable sensors detect clinically meaningful impairments before they become apparent during routine neurological examination.
The diagnostic sensitivity of IMU-based assessments is particularly evident during postural control tasks. Carpinella et al. (2022) demonstrated that advanced analysis of quiet standing using wearable sensors was three to four times more sensitive than conventional Romberg testing. Specifically, early RRMS participants exhibited reduced sway complexity and increased trunk oscillations, allowing balance impairment to be identified in 58% of participants compared with only 17% detected using traditional clinical assessment. These findings strongly support the integration of wearable technologies into the early evaluation of balance dysfunction in MS.
Although neuroimaging studies have documented widespread functional reorganization in MS, relatively little is known about the neural mechanisms specifically underlying vestibular dysfunction and balance impairment during the early stages of the disease. Task-based fMRI consistently demonstrates increased activation of sensorimotor cortical regions, suggesting compensatory recruitment of motor networks, while resting-state studies reveal altered connectivity within sensorimotor and vestibular circuits. Furthermore, diffusion tensor imaging studies have shown that the structural integrity of proprioceptive pathways predicts balance performance in people with MS (Fling et al., 2014). Nevertheless, to our knowledge, no previous study has combined functional MRI with balance-related vestibular stimulation to directly investigate the neural correlates of early balance impairment in RRMS. This represents a significant knowledge gap.
Immersive virtual reality (VR) offers an innovative approach for investigating balance control under controlled sensory conflict conditions. Beyond its diagnostic potential, VR may also serve as a rehabilitation tool by repeatedly exposing patients to visual and vestibular challenges that promote sensory reweighting. Recent technological developments have led to the creation of MRI-compatible VR systems capable of presenting gaze-controlled visual environments during brain imaging. Such platforms provide the opportunity to investigate how the brain processes balance-related visual and vestibular stimuli in vivo and may eventually facilitate the development of individualized neurorehabilitation protocols.
Vestibular Physical Therapy (VPT) represents one of the most promising rehabilitation strategies for addressing balance dysfunction in MS. VPT consists of structured exercises involving head and eye movements, gaze stabilization, postural control, and balance tasks designed to promote central vestibular compensation (Tramontano et al., 2025). Although vestibular dysfunction in MS is often central rather than peripheral in origin, growing evidence supports the effectiveness of VPT in improving both dizziness and balance (Tramontano et al., 2021).
A recent meta-analysis demonstrated that vestibular rehabilitation significantly improves balance performance and reduces dizziness compared with no intervention in people with MS, with large clinical effect sizes (García-Muñoz et al., 2020). Although vestibular rehabilitation was not statistically superior to other forms of exercise therapy, it consistently produced greater improvements across studies. Similarly, Smania et al. (2015) showed that sensory integration-based balance training resulted in significantly greater improvements in balance performance, reduced falls, and increased balance confidence compared with conventional rehabilitation.
The beneficial effects of VPT are believed to result from adaptive neuroplastic mechanisms. Vestibular rehabilitation facilitates sensory reweighting by enhancing the integration of visual, vestibular, and proprioceptive information while promoting adaptation of vestibulo-ocular and vestibulo-spinal reflexes. Experimental animal studies further suggest that structured vestibular rehabilitation induces cellular plasticity within vestibular nuclei, accelerating functional recovery through increased microgliogenesis and regulation of neurogenesis (Marouane et al., 2021). In humans, neurorehabilitation studies have similarly reported increased functional connectivity within cerebellar and sensorimotor networks following rehabilitation, supporting the hypothesis that VPT promotes adaptive reorganization of central balance networks.
Despite these advances, important unmet clinical needs remain. First, currently available clinical assessments lack sufficient sensitivity to detect early balance impairment in RRMS. Standard neurological examination and conventional balance tests frequently fail to identify subtle deficits that are readily detected using wearable technologies. Second, the neural mechanisms underlying early balance dysfunction remain poorly understood, particularly regarding the interaction between vestibular, cerebellar, and cortical networks. Finally, vestibular rehabilitation is generally introduced only after moderate disability has developed (EDSS 3-6), despite evidence that many patients experience instability much earlier. This delay represents a missed opportunity for preventive intervention aimed at preserving mobility and reducing long-term disability.
These limitations provide a strong rationale for the proposed study. By combining objective gait analysis using wearable inertial sensors, advanced functional neuroimaging with vestibular stimulation, and an early Vestibular Physical Therapy program specifically targeting visuo-vestibular integration and sensory reweighting, this project seeks to characterize the mechanisms underlying early balance impairment in RRMS and determine whether timely intervention can modify both functional performance and the neural substrates of balance control. Demonstrating the efficacy of early VPT could support a paradigm shift toward proactive rehabilitation in Multiple Sclerosis, enabling clinicians to identify and treat balance dysfunction before irreversible disability develops.
Hypothesis
We hypothesize that individuals with early relapsing-remitting Multiple Sclerosis (RRMS; EDSS ≤ 2.5) exhibit measurable neurophysiological alterations within vestibular and sensorimotor networks despite minimal clinical disability, and that these alterations contribute to the subtle balance impairments commonly reported during the early stages of the disease. We further hypothesize that a targeted Vestibular Physical Therapy (VPT) program, specifically designed to promote sensory reweighting and visuo-vestibular integration, will improve both subjective symptoms and objective balance performance while inducing adaptive neuroplastic changes detectable by functional MRI (fMRI).
Specifically, we propose that the "hidden" imbalance observed in early RRMS reflects compensatory or maladaptive plasticity within vestibular, cerebellar, and sensorimotor circuits. These alterations are expected to manifest as abnormal patterns of functional activation and connectivity on fMRI. By engaging vestibular pathways through a structured rehabilitation program, we anticipate promoting adaptive reorganization of these networks, resulting in improved balance control, enhanced gaze stability, and normalization of functional brain connectivity.
This hypothesis is supported by previous evidence demonstrating increased activation of sensorimotor and vestibular cortical regions during motor tasks in early MS, as well as studies showing that motor rehabilitation modifies functional connectivity in people with MS. Furthermore, vestibular rehabilitation has been shown to induce cerebellar and brainstem plasticity in other neurological populations. However, no previous study has directly investigated these mechanisms in early RRMS using an integrated multimodal approach combining functional neuroimaging, quantitative gait analysis, and vestibular rehabilitation.
Specific Aims Aim 1. Identify the Neuroimaging Correlates of Early Balance Dysfunction
Participants will undergo structural and functional MRI using advanced imaging protocols to characterize the functional organization of vestibular, sensorimotor, cerebellar, and balance-related brain networks. Functional imaging will include vestibular stimulation paradigms, such as controlled acoustic stimulation and, where feasible, visual motion stimuli presented through MRI-compatible immersive virtual reality.
We hypothesize that individuals with RRMS will demonstrate altered functional connectivity among key regions involved in balance control, including the cerebellum, parietal cortex, vestibular brainstem nuclei, and sensorimotor cortex, compared with healthy controls. Furthermore, we expect these neuroimaging abnormalities to correlate with the severity of balance impairment measured through objective gait analysis, providing neurophysiological biomarkers of early balance dysfunction.
Aim 2. Characterize Early Balance Impairment Using Advanced Clinical and Instrumented Measures
Subjective and objective balance performance will be comprehensively evaluated using validated clinical questionnaires, standardized balance assessments, and wearable inertial measurement units (IMUs).
Patient-reported outcomes will include measures of dizziness, balance confidence, and quality of life, while IMUs will quantify gait characteristics-including walking speed, stride length, gait symmetry, smoothness, and postural stability-during standardized walking tasks and quiet standing.
We expect people with early RRMS (EDSS ≤ 2.5) to exhibit measurable impairments in gait and postural control despite minimal disability on conventional neurological examination, confirming the presence of clinically hidden balance dysfunction.
Aim 3. Evaluate the Effects of Targeted Vestibular Physical Therapy
We will conduct a randomized crossover clinical trial in which each participant serves as their own control, thereby maximizing statistical power while minimizing inter-individual variability.
Participants will complete both:
a 4-week Vestibular Physical Therapy (VPT) program consisting of 12 sessions specifically designed to enhance sensory reweighting, visuo-vestibular integration, gaze stability, and saccadic function; and a 4-week control period consisting of standard clinical management without additional vestibular rehabilitation.
Participants initially randomized to the intervention arm will undergo a 4-week washout period before crossing over to the control condition, whereas no washout will be required for participants initially assigned to the control arm.
Clinical assessments, quantitative gait analysis, and functional MRI will be performed before and after each intervention period.
We hypothesize that VPT will produce significantly greater improvements in balance performance, gait parameters, dizziness, and fatigue compared with the control condition. We further expect these functional improvements to be accompanied by adaptive changes in brain connectivity, including normalization of excessive cerebellar-sensorimotor coupling and enhanced integration within vestibular networks.
Importantly, vestibular stimulation delivered during fMRI through controlled acoustic stimuli will provide a direct measure of functional changes within vestibular pathways following rehabilitation, offering mechanistic insight into the neural effects of VPT on postural control and gaze stabilization.
Aim 4. Develop Integrated Biomarkers of Early Balance Dysfunction and Rehabilitation Response
Finally, we will integrate quantitative gait metrics obtained from wearable sensors with functional neuroimaging data to identify multimodal biomarkers of early balance impairment.
Specifically, we will investigate whether individuals exhibiting greater abnormalities in gait and postural control also demonstrate more pronounced alterations in vestibular network connectivity. We will additionally evaluate whether changes in these imaging biomarkers predict clinical improvement following rehabilitation.
The identification of objective biomarkers linking behavior and brain function could facilitate earlier diagnosis, improve patient stratification, and provide sensitive outcome measures for future rehabilitation trials.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| VPT | Experimental | Other: Vestibular Physical TherapyPeople in this arm will be treated with a vestibular physical therapy programme. |
| No VPT | No intervention | –People in this arm will receive a no-add-on-intervention period |
| Healty control | No intervention | –A healthy control group is required to enable comparisons between individuals with MS and healthy participants. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- people with Relapsing-Remitting Multiple Sclerosis;
- All participants must be ambulatorial (EDSS ≤2.5);
Key exclusion criteria (4 listed)
- relapse or medication changes in the prior 6 months;
- people with peripheral vestibular disorders;
- people with contraindications to MRI.
- We will also recruit 30 healthy volunteers, matched for age and sex, who will complete the assessment protocol once, to serve as a comparison group for individuals with MS.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Vestibular Physical TherapyVestibular Physical Therapy sessions realized focusing on visuo-vestibular interaction (12 session, 3 x 4 weeks) | Other | VPT |
Primary outcome
Mini-BESTest
Time frame: Baseline (T0), after first intervention period (T1; 4 weeks), and after crossover (T2; 8 weeks).
is a 14-item scale (0-28) measures anticipatory postural adjustments, reactive control, sensory orientation and dynamic gait. It is validated and reliable in people with MS. Test-retest reliability is "good to excellent" in mild/moderate MS. Higher scores indicate better balance stability.
7 secondary outcomes
Neuroimaging (MRI)
Time frame: Baseline (T0), after first intervention period (T1; 4 weeks), and after crossover (T2; 8 weeks).
Berg Balance Scale (BBS)
Time frame: Baseline (T0), after first intervention period (T1; 4 weeks), and after crossover (T2; 8 weeks).
Dizziness Handicap Inventory (DHI)
Time frame: Baseline (T0), after the first intervention period (T1; 4 weeks), and after the crossover intervention (T2; 8 weeks).
Activities-specific Balance Confidence (ABC) Scale
Time frame: Baseline (T0), after the first intervention period (T1; 4 weeks), and after the crossover intervention (T2; 8 weeks).
Fatigue Severity Scale
Time frame: Baseline (T0), after the first intervention period (T1; 4 weeks), and after the crossover intervention (T2; 8 weeks).
Inertial Measurement Unit (IMU)-derived Gait Parameters
Time frame: Baseline (T0), after the first intervention period (T1; 4 weeks), and after the crossover intervention (T2; 8 weeks).
IMU-derived Gait Parameters
Time frame: Baseline (T0), after the first intervention period (T1; 4 weeks), and after the crossover intervention (T2; 8 weeks).
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Sep 2026.
- Background: PubMed 39973598Tramontano M, Paolocci G, Piatti D, Attanasio G, Casagrande Conti L, Bergamini E, Manzari L, Lacquaniti F, Staab JP, Bosco G, Indovina I. Dynamic postural stability, symmetry, and smoothness of gait in patients with persistent postural-perceptual dizziness. J Vestib Res. 2025 Mar;35(2):82-90. doi: 10.1177/09574271241295615. Epub 2024 Nov 6.
- Background: PubMed 42084487Piatti D, Paolocci G, Verdecchia DH, Grasso MG, Bosco G, Indovina I, Tramontano M. Effectiveness of vestibular physical therapy on balance and dizziness in people with multiple sclerosis: A systematic review and meta-analysis. J Vestib Res. 2026 May 5:9574271261444952. doi: 10.1177/09574271261444952. Online ahead of print.
- Background: PubMed 32356754Caronni A, Gervasoni E, Ferrarin M, Anastasi D, Brichetto G, Confalonieri P, Di Giovanni R, Prosperini L, Tacchino A, Solaro C, Rovaris M, Cattaneo D, Carpinella I. Local Dynamic Stability of Gait in People With Early Multiple Sclerosis and No-to-Mild Neurological Impairment. IEEE Trans Neural Syst Rehabil Eng. 2020 Jun;28(6):1389-1396. doi: 10.1109/TNSRE.2020.2991636. Epub 2020 Apr 30.
- Individual participant dataSharing planned: No
Related trials for Multiple Sclerosis
RecruitingPhase 2
Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)
Multiple Sclerosis
RecruitingObservational study
Pain Phenotypes in Individuals With Multiple Sclerosis
Multiple Sclerosis, Chronic Pain
Not yet recruiting
Evaluating the Effect of the Zeen Mobility Device on Clinical Practicality, Safety, and Impact (Via Assessments of Walking, Standing Tolerance, Balance, Endurance, Effort, and Participation in Daily Tasks) in an Outpatient Rehabilitation Setting for Individuals With Mobility Impairments.
Stroke, Parkinson's Disease (PD)
RecruitingPhase 3
Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis
Multiple Sclerosis
RecruitingPhase 2
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
Multiple Sclerosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Maria Grazia Grasso, MD, PhD principal investigator
LIFE - Research and Care Institute - Santa Lucia IRCCS
Diego Piatti, PT, MSc study director
LIFE - Research and Care Institute - Santa Lucia IRCCS
Iole Indovina, PhD study chair
LIFE - Research and Care Institute - Santa Lucia IRCCS
Questions about this trial
What is this clinical trial studying?
A study testing Vestibular Physical Therapy in people with Multiple Sclerosis, run by LIFE - Research and Care Institute - Santa Lucia IRCCS.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 4 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Mini-BESTest (time frame: Baseline (T0), after first intervention period (T1; 4 weeks), and after crossover (T2; 8 weeks).). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07805733, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Sep 2026.